Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002963 · ClinicalTrials.gov registry record · Phase 2
Photodynamic Therapy in Treating Patients With Skin Cancer
A Phase 2 study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00002963 is a Phase 2 study that has completed, run by Roswell Park Cancer Institute.
The verdict
NCT00002963, a Phase 2 study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy using aminolevulinic acid cream may be effective in treating patients with skin cancer. PURPOSE: This randomized phase II trial is studying how well photodynamic therapy works in treating patients with skin cancer.
Interventions
- PROCEDURE conventional surgery
- DRUG aminolevulinic acid hydrochloride
Trial Details
| Field | Value |
|---|---|
| Start Date | 1993-11 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002963
The ClinicalTrials.gov registry entry for NCT00002963 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which conventional surgery is the first listed.
NCT00002963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002963 about?
NCT00002963 is a clinical study titled "Photodynamic Therapy in Treating Patients With Skin Cancer". RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy using aminolevulinic acid cream may be effective in treating patients with skin cancer. PURPOSE: This randomized phase II trial is studying how well photodyn...
What is the current status of trial NCT00002963?
This trial is currently completed. It is a Phase 2 study. The study started on 1993-11. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00002963?
The interventions under investigation include: conventional surgery (PROCEDURE), aminolevulinic acid hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00002963?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.